Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

Cancer Research UK scientists announce ‘breakthrough’ in understanding of metastasis

The team found that cancer cells ‘exploit’ the body’s tissue repair process to spread cells

- PMLiVE

Sanofi and Regeneron’s Dupixent approved by FDA for prurigo nodularis

The two phase 3 trials showed a meaningful reduction in itching

Modern Medical Affairs: How to Leverage Tech and Data as an MSL

Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...

Impetus Digital

- PMLiVE

The Creative Engagement Group appoints Tom Griffiths from Saatchi & Saatchi Wellness as Strategy and Planning Director

The Creative Engagement Group has appointed experienced healthcare and digital strategist Tom Griffiths.

The Creative Engagement Group

Is communication failing us?

Compelling people to care in a world oversaturated with news and information

Page & Page Health

- PMLiVE

Are your field teams ready to excel in the new era?

A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs.

The Creative Engagement Group

The Sofa Sessions – The Sixth Page

Page & Page Health

- PMLiVE

WHO and ILO call for ‘concrete actions’ to address mental health issues at work

An estimated 12 billion work days are lost annually due to depression and anxiety, WHO reports

- PMLiVE

World Heart Day highlights actions to prevent and control cardiovascular disease

CVD is the world’s leading cause of death, resulting in 18.6 million global deaths each year

- PMLiVE

Shionogi’s antiviral COVID-19 treatment meets phase 3 primary endpoint

Ensitrelvir reduced the time taken to resolve five key symptoms

- PMLiVE

Biogen and Eisai’s lecanemab shows promise in confirmatory Alzheimer’s study

Results from the phase 3 trial showed reduction in clinical decline

5 Healthcare Marketing Blunders | How To Avoid Them.

5 Healthcare Marketing Blunders | How To Avoid Them.

Here are 5 healthcare marketing blunders and how best to avoid them.

The Good Ideas Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links